Have questions? Visit https://www.reddit.com/r/SNPedia

rs1044129

From SNPedia

Orientationplus
Stabilizedplus
Make rs1044129(A;A)
Make rs1044129(A;G)
Make rs1044129(G;G)
ReferenceGRCh38 38.1/141
Chromosome15
Position33866065
GeneAVEN, RYR3
is asnp
is mentioned by
dbSNPrs1044129
dbSNP (classic)rs1044129
ClinGenrs1044129
ebirs1044129
HLIrs1044129
Exacrs1044129
Gnomadrs1044129
Varsomers1044129
LitVarrs1044129
Maprs1044129
PheGenIrs1044129
Biobankrs1044129
1000 genomesrs1044129
hgdprs1044129
ensemblrs1044129
geneviewrs1044129
scholarrs1044129
googlers1044129
pharmgkbrs1044129
gwascentralrs1044129
openSNPrs1044129
23andMers1044129
SNPshotrs1044129
SNPdbers1044129
MSV3drs1044129
GWAS Ctlgrs1044129
GMAF0.4275
Max Magnitude0
? (A;A) (A;G) (G;G) 28


[PMID 21810988OA-icon.png] Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification


[PMID 17584784OA-icon.png] Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.


[PMID 23393343] Functional Polymorphism in the MicroRNA-367 Binding Site as a Prognostic Factor for Colonic Cancer


[PMID 24530479] A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma


[PMID 24831772] A polymorphism at the microRNA binding site in the 3' untranslated region of C14orf101 is associated with non-Hodgkin lymphoma overall survival


[PMID 24922658] Genetic Polymorphism of miR-196a as a Prognostic Biomarker for Early Breast Cancer


[PMID 26309413OA-icon.png] A polymorphism at the microRNA binding site in the 3' untranslated region of RYR3 is associated with outcome in hepatocellular carcinoma


[PMID 27602096OA-icon.png] A polymorphism at the microRNA binding site in the 3'-untranslated region of C14orf101 is associated with the risk of gastric cancer development.


[PMID 32678982] A Polymorphism at the microRNA Binding Site in the 3' Untranslated Region of KRT81 Is Associated with Breast Cancer.